Personalized Therapy Target potential collaborations around biopsy-driven drug matching and companion diagnostics services for precision oncology, leveraging StrandSmart's capability to analyze live cancer cells to determine effective therapies for individual patients.

Small-Team Agility Leverage the company’s small size and focused team to position rapid pilot programs and early-access partnerships with pharma, biotech startups, or CROs seeking agile collaboration on liquid biopsy workflows.

Clinical Validation Highlight opportunities to co-create or sponsor clinical validation studies, given StrandSmart’s niche in live-cell analysis, to accelerate evidence generation for potential drug efficacy and patient stratification.

Strategic Funding Explore co-investment or grant-supported projects with research institutions and biotech investors, aligning StrandSmart’s modest revenue with funded R&D efforts to expand capabilities and market reach.

Digital Presence Capitalize on their existing digital tools by offering integrated marketing, analytics, and partner enablement services to increase visibility, streamline collaboration, and track outcomes across research and development partnerships.